Protalix BioTherapeutics (PLX) Current Taxes (2023 - 2026)

Protalix BioTherapeutics' Current Taxes history runs 4 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Current Taxes fell 7.85% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 7.85% YoY), while the FY2025 annual figure was $2.9 million, down 15.13% from the prior year.
• Current Taxes was $3.2 million for Q1 2026 at Protalix BioTherapeutics, up from $2.9 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $3.7 million in Q2 2025 to a low of $2.4 million in Q3 2025.
• Historically, Current Taxes has averaged $3.2 million across 4 years, with a median of $3.2 million in 2026.
• The sharpest annual moves came in 2024 and 2025: Current Taxes rose 20.86% in 2024, then declined 15.13% in 2025.
• A 4-year view of Current Taxes shows it stood at $2.9 million in 2023, then grew by 20.86% to $3.5 million in 2024, then decreased by 15.13% to $2.9 million in 2025, then climbed by 8.58% to $3.2 million in 2026.
• The last three Current Taxes figures came in at $3.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.